Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis

World Journal of Urology

Volumn 24, Issue 1, 2006, Pages 33-38

  Lee, Seung Ju ^a   Kim, Sae Woong ^b   Cho, Yong Hyun ^b   Yoon, Moon Soo ^b  

^a Sam Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cystitis; Escherichia coli; Immunization; Lipopolysaccharides; Mice

Indexed keywords

LIPOPOLYSACCHARIDE; OM 8930; OM-8930;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CYSTITIS; DESENSITIZATION; DISEASE MODEL; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; METHODOLOGY; MOUSE; NEEDLE BIOPSY; PATHOLOGY; PROBABILITY; RANDOMIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOPSY, NEEDLE; CYSTITIS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 33644530968     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00345-005-0046-y     Document Type: Article

References (25)

1. Sobel JD (1991) Bacterial etiologic agents in the pathogenesis of urinary tract infection. Med Clin North Am 75:253-273
2. Hooton TM, Scholes D, Hughes JP et al (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468-474
3. Stamm WE, Hooton TM (1993) Management of urinary tract infections in adults. N Engl J Med 329:1328-1334
4. Foxman B (1990) Recurring urinary tract infection: Incidence and risk factors. Am J Public Health 80:331-333
5. Bauer HW, Rahlfs VW, Lauener PA, Blessmann GS (2002) Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents 19:451-456
6. Frey C, Obolensky W, Wyss H (1986) Treatment of recurrent urinary tract infections: Efficacy of an orally administered biological response modifier. Urol Int 41:444-446
7. Hachen HJ (1990) Oral immunotherapy in paraplegic patients with chronic urinary tract infections: A double-blind, placebo-controlled trial. J Urol 143:759-763
8. Schulman CC, Corbusier A, Michiels H, Taenzer HJ (1993) Oral immunotherapy of recurrent urinary tract infections: A double-blind placebo-controlled multicenter study. J Urol 150:917-921
9. Magasi P, Panovics J, Illes A, Nagy M (1994) Uro-Vaxom and the management of recurrent urinary tract infection in adults: A randomized multicenter double-blind trial. Eur Urol 26:137-140
10. Lettgen B (1996) Prevention of recurrent urinary tract infections in female children. Curr Ther Res 57:464-475
11. Wybran J, Libin M, Schandene L (1989) Enhancement of cytokine production and natural killer activity by an Escherichia coli extract. Onkologie 3(Suppl 12):22-25
12. Hockertz S (1990) Immunomodulatory effect of lysed immunoactive fractions of selected Escherichia coli strains on the macrophage system. An in vitro study. Arzneimittelforschung 40:1068-1072
13. Van Pham T, Kreis B, Corradin-Betz S, Bauer J, Mauel J (1990) Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): In vitro studies. J Biol Response Mod 9:231-240
14. Bessler WG, Kleine B, Martinez Alonso C et al (1990) Biological activity of bacterial surface components: Bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung 168(Suppl):707-715
15. Bessler WG, Beck P, Konetznick U et al (1991) Biological activity of bacterial surface components. Immunogenicity and immunomodulatory properties of a bacterial extract from Escherichia coli. Arzneimittelforschung 41:274-279
16. Huber M, Baier W, Serr A, Bessler WG (2000) Immunogenicity of an E. coli extract after oral or intraperitoneal administration: Induction of antibodies against pathogenic bacterial strains. Int J Immunopharmacol 22:57-68
17. Sedelmeier EA, Bessler WG (1995) Biological activity of bacterial cell-wall components: Immunogenicity of the bacterial extract OM-89. Immunopharmacology 29:29-36
18. Raetz CR (1993) Bacterial endotoxins: Extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol 175:5745-5753
19. Dupont MC, Spitsbergen JM, Kim KB, Tuttle JB, Steers WD (2001) Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166:1111-1118
20. Jerde TJ, Bjorling DE, Steinberg H, Warner T, Saban R (2000) Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol Res 28:269-273
21. Cook EB, Stahl JL, Lowe L et al (2001) Simultaneous measurement of six cytokines in a single of human tears using microparticle-based flow cytometry: Allergics vs. non-allergics. J Immunol Methods 254:109-118
22. Wolpe SD, Cerami A (1989) Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 3:2565-2573
23. Olson NC, Hellyer PW, Dodam JR (1995) Mediators and vascular effects in response to endotoxin. Br Vet J 151:489-522
24. Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17:259-268
25. Stamm WE, McKevitt M, Roberts PL, White NJ (1991) Natural history of recurrent urinary infections in women. Rev Infect Dis 13:77-84